Top Markets
Coin of the day
WPD Pharmaceuticals Inc. WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.

WBIO
Rank in Stocks #34462
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver,... WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
Share Price
$0.04895618
Last synced: 2025-03-18
Market Cap
$5.55M
Change (1 day)
-0.04%
Change (1 year)
0.00%
Country
CA
Trade WPD Pharmaceuticals Inc. (WBIO)

Category

Stock split history for WPD Pharmaceuticals Inc. (WBIO)
WPD Pharmaceuticals Inc. stock (symbol: WBIO) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 17, 2026.
One WBIO share bought prior to Aug 17, 2026 would equal to 0 WBIO shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE